Delivery Order SPE2DB20D1109-SPE2DB21FP96Y

Award Date 9/8/21
Potential Completion Date 9/9/21
Potential Value $2.3K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PROAIR HFA 90 MCG INHALER 8.5GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor for this $1,092.64 firm-fixed-price delivery order is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support...
This federal contract award, valued at $2,476.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of PROAIR HFA 90 MCG INHALER 8.5GM, a medical product. This award is a Delivery Order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC...
This federal contract award is for the delivery of ProAir HFA 90 MCG inhalers to the Defense Logistics Agency (DLA). The $2,221.32 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 31, 2022 and was not set aside for any special designation. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical,...
This federal contract award is for the delivery of PROAIR HFA 90 MCG INHALER 8.5GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,122.00 and an ultimate completion date of September 20, 2022. This is a firm fixed-price delivery order, and the contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award is for the delivery of ProAir HFA 90 MCG inhalers to the Defense Logistics Agency (DLA). The $1,921.55 firm-fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is a major pharmaceutical distributor that serves as a critical vendor for federal healthcare programs, particularly within military and veterans'...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,690.04 firm fixed-price delivery order covers the supply of ProAir HFA 90 MCG Inhalers. The award is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc. (doing business as Amerisourcebergen), valued at up to $999,999,999.00 through November 2026. This...
This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,077.12 firm fixed-price contract is for the supply of PROAIR HFA 90 MCG INHALER 8.5GM, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of ProAir HFA 90 MCG Inhaler 8.5GM to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,292.83 and a completion date of May 9, 2022. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of PROAIR HFA 90 MCG INHALER 8.5GM. The $2,941.61 fixed-price delivery order contract has a performance period ending on December 29, 2021. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of PROAIR HFA 90 MCG INHALER 8.5GM to the Defense Logistics Agency (DLA), a major procurement agency for the Department of Defense (DoD). The contract, valued at $1,234.20, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB21FP96Y
    Delivery Order

This federal contract award is for the delivery of Proair HFA 90 MCG Inhaler 8.5GM to the Defense Logistics Agency (DLA). The $2,275.04 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor that holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company is Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:18 AM